These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30314513)

  • 1. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway.
    Peng Y; Wang Y; Tang N; Sun D; Lan Y; Yu Z; Zhao X; Feng L; Zhang B; Jin L; Yu F; Ma X; Lv C
    J Exp Clin Cancer Res; 2018 Oct; 37(1):248. PubMed ID: 30314513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling.
    Xiao X; Shi D; Liu L; Wang J; Xie X; Kang T; Deng W
    PLoS One; 2011; 6(8):e22934. PubMed ID: 21857970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
    Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
    J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.
    Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W
    J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway.
    Pasha A; Kumar K; Heena SK; Arnold Emerson I; Pawar SC
    Sci Rep; 2024 May; 14(1):12020. PubMed ID: 38797813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
    Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
    Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase/Akt signaling pathway.
    Kumar S; Patil HS; Sharma P; Kumar D; Dasari S; Puranik VG; Thulasiram HV; Kundu GC
    Curr Mol Med; 2012 Sep; 12(8):952-66. PubMed ID: 22804248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.
    Yu X; Li W; Deng Q; You S; Liu H; Peng S; Liu X; Lu J; Luo X; Yang L; Tang M; Weng X; Yi W; Liu W; Wu S; Ding Z; Feng T; Zhou J; Fan J; Bode AM; Dong Z; Liu J; Cao Y
    Mol Carcinog; 2017 May; 56(5):1414-1426. PubMed ID: 27996164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways.
    Yi C; Zhang Y; Yu Z; Xiao Y; Wang J; Qiu H; Yu W; Tang R; Yuan Y; Guo W; Deng W
    PLoS One; 2014; 9(7):e99943. PubMed ID: 25000190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
    Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
    PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
    Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
    Zhang Z; Zheng F; Yu Z; Hao J; Chen M; Yu W; Guo W; Chen Y; Huang W; Duan Z; Deng W
    PLoS One; 2017; 12(10):e0186900. PubMed ID: 29049411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbrokinase Extracted from
    Hua C; Guo Z; Dai M; Zhou J; Ge H; Xue G; Xu F; Ru L; Lv K; Zhang G; Zheng L; Wang M; Teng Y; Yu W; Guo W
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
    Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z
    Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.
    Zhou Z; Mao W; Li Y; Qi C; He Y
    Anat Rec (Hoboken); 2019 Dec; 302(12):2186-2192. PubMed ID: 31266091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.